Reply

Affiliations

Comment

Ilkay Kilic Muftuoglu et al. Am J Ophthalmol. 2017 Jan.

. 2017 Jan:173:146.

doi: 10.1016/j.ajo.2016.09.023. Epub 2016 Nov 11.

No abstract available

Comment on

Long-Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Persistent Neovascular Age-Related Macular Degeneration.
Muftuoglu IK, Arcinue CA, Tsai FF, Alam M, Gaber R, Camacho N, You Q, Freeman WR. Muftuoglu IK, et al. Am J Ophthalmol. 2016 Jul;167:1-9. doi: 10.1016/j.ajo.2016.03.038. Epub 2016 Apr 2. Am J Ophthalmol. 2016. PMID: 27049000
Long-Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Persistent Neovascular Age-Related Macular Degeneration.
Călugăru D, Călugăru M. Călugăru D, et al. Am J Ophthalmol. 2017 Jan;173:145-146. doi: 10.1016/j.ajo.2016.07.029. Epub 2016 Nov 11. Am J Ophthalmol. 2017. PMID: 27842696 No abstract available.